OPKO Health
OPK Small CapHealthcare · Diagnostics & Research
Aktualisiert: Apr 5, 2026, 17:43 UTC
Kennzahlen
Bewertungs-Analyse
Über das Unternehmen
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose a
Trading-Daten
Ähnliche Aktien aus dem Sektor
Wo kann ich OPKO Health kaufen?
Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.
